Form 4: Colgate-Palmolive Director Defers Retainer to Stock
Insider Transaction
Colgate-Palmolive Director Brian Newman acquired 228 shares of common stock by deferring a portion of his annual cash retainer.
Summary
- Brian Newman, a Director of Colgate-Palmolive Company (CL), acquired 228 shares of common stock.
- The transaction occurred on October 1, 2025, at a price of $82.13 per share.
- This acquisition was a result of deferring a portion of his annual cash retainer into a stock unit account, pursuant to the Deferred Compensation Plan for Non-Employee Directors.
- Following this transaction, Brian Newman directly beneficially owns 5,065 shares of common stock.
- Additionally, 36 shares are indirectly beneficially owned by a Family Trust.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive as it reflects a director's decision to increase their stake in the company through a deferred compensation plan, indicating confidence and alignment of interests. However, it is a routine, pre-scheduled transaction rather than a discretionary open-market purchase, limiting its overall impact on sentiment.
Positives
- The acquisition of shares by a director demonstrates continued alignment of management and director interests with those of shareholders.
- Participation in the Deferred Compensation Plan for Non-Employee Directors indicates confidence in the company's long-term performance.
Future Outlook
N/A
Industry Context
N/A
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compensation Policy | The transaction was executed pursuant to the Deferred Compensation Plan for Non-Employee Directors, allowing directors to defer cash retainers into stock units. | N/A | This plan aligns the financial interests of non-employee directors with long-term shareholder value by increasing their equity ownership in the company. |
Stakeholder Impact
- Shareholders: The transaction reinforces confidence in the company's leadership and aligns director incentives with shareholder returns, potentially fostering long-term value creation.
Key Dates
| Date | Description |
|---|---|
| 10/01/2025 | Date of transaction for the acquisition of common stock. |
| 10/03/2025 | Date the Form 4 was signed by the reporting person's attorney-in-fact. |
Recommendation
holdThis Form 4 reports a routine acquisition of shares by a director as part of a deferred compensation plan. While it indicates continued insider ownership and alignment of interests, it is not a significant event that would alter the fundamental investment thesis for Colgate-Palmolive stock. Investors should continue to hold based on broader company performance and market conditions, as this transaction does not provide new material information to warrant a change in investment strategy.
Keywords
Colgate-Palmolive, CL, Brian Newman, Form 4, Insider Transaction, Director Compensation, Stock Acquisition, Deferred Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.